The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and the Risk of Hospitalization for Pneumonia
Abstract
RATIONALE: Inhaled corticosteroids are commonly prescribed to patients with chronic obstructive pulmonary disease (COPD). OBJECTIVES: To examine whether these medications might be associated with an excess risk of pneumonia. METHODS: We conducted a nested case-control study within a cohort of patients with COPD from Quebec, Canada, over the period 1988-2003, identified on the basis of administrative databases linking hospitalization and drug-dispensing information. Each subject hospitalized for pneumonia during follow-up (case subjects) was age and time matched to four control subjects. The effect of the use of inhaled corticosteroids was assessed by conditional logistic regression, after adjusting for comorbidity and COPD severity. MEASUREMENTS AND MAIN RESULTS: The cohort included 175,906 patients with COPD of whom 23,942 were hospitalized for pneumonia during follow-up, for a rate of 1.9 per 100 per year, and matched to 95,768 control subjects. The adjusted rate ratio of hospitalization for pneumonia associated with current use of inhaled corticosteroids was 1.70 (95% confidence interval [CI], 1.63-1.77) and 1.53 (95% CI, 1.30-1.80) for pneumonia hospitalization followed by death within 30 days. The rate ratio of hospitalization for pneumonia was greatest with the highest doses of inhaled corticosteroids, equivalent to fluticasone at 1,000 microg/day or more (rate ratio, 2.25; 95% CI, 2.07-2.44). All-cause mortality was similar for patients hospitalized for pneumonia, whether or not they had received inhaled corticosteroids in the recent past (7.4 and 8.2%, respectively). CONCLUSIONS: The use of inhaled corticosteroids is associated with an excess risk of pneumonia hospitalization and of pneumonia hospitalization followed by death within 30 days, among elderly patients with COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Guidelines for the diagnosis and management of asthma.
Solomon, P. A. (1992) · PubMed · Cited by 2,004
National Hospital Discharge Survey, 1988: Archival Version
United States Department of Health and Human Services. National Center for Health Statistics (1991) · ICPSR Data Holdings · doi:10.3886/icpsr09521 · Cited by 1,310
Pauwels, R. A., Löfdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402503 · Cited by 1,074
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
Niewoehner, D. E., Erbland, M. L., Deupree, R. H., Collins, D., Gross, N. J., Light, R. W., Anderson, P., & Morgan, N. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402502 · Cited by 875
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432601 · Cited by 830
Vestbo, J., Søorensen, T., Lange, P., Brix, A., Torre, P., & Viskum, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10019-3 · Cited by 816
Tamblyn, R., Lavoie, G., Petrella, L., & Monette, J. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00234-h · Cited by 577
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.
Boulet, L. P., Becker, A. B., Bérubé, D., Beveridge, R., & Ernst, P. (1999) · Europe PMC (PubMed Central) · Cited by 536
Self-citationWolfe, F., Caplan, L., & Michaud, K. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21568 · Cited by 480
National Hospital Discharge Survey: 2003 annual summary with detailed diagnosis and procedure data.
Kozak, L. J., Lees, K. A., & DeFrances, C. J. (2006) · PubMed · Cited by 422
CULPITT, S. V., MAZIAK, W., LOUKIDIS, S., NIGHTINGALE, J. A., MATTHEWS, J. L., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9811058 · Cited by 417
Alsaeedi, A., Sin, D. D., & McAlister, F. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01143-9 · Cited by 326
Kardos, P., Wencker, M., Glaab, T., & Vogelmeier, C. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-244oc · Cited by 314
Risk factors for community-acquired pneumonia in adults: a population-based case-control study
Almirall, J., Bolibar, I., Balanzo, X., & Gonzalez, C. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.13234999 · Cited by 272
Risk factors for community-acquired pneumonia diagnosed upon hospital admission
Farr, B. M., Bartlett, C. L. R., Wadsworth, J., & Miller, D. L. (2000) · Respiratory Medicine · doi:10.1053/rmed.2000.0865 · Cited by 166
Inhaled and Nasal Corticosteroid Use and the Risk of Fracture
Suissa, S., Baltzan, M., Kremer, R. B., & Ernst, P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-640oc · Cited by 153
Self-citationSuissa, S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1338pp · Cited by 136
Self-citationLow-dose inhaled and nasal corticosteroid use and the risk of cataracts
Ernst, P., Baltzan, M., Deschênes, J., & Suissa, S. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00043005 · Cited by 123
Self-citationThe defined daily dose system (DDD) for drug utilization review.
Ai, W. (1986) · PubMed · Cited by 105
Lange, P., Vestbo, J., & Nyboe, J. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08101694 · Cited by 105
Andel, A. E. V., Reisner, C., Menjoge, S., & Tj, W. (1999) · CHEST Journal · doi:10.1378/chest.115.3.703 · Cited by 57
Cited by
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Suissa, S., Dell'Aniello, S., & Ernst, P. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201518 · Cited by 779
Self-citationO’Donnell, D. E., Aaron, S., Bourbeau, J., Hernandez, P., Marciniuk, D. D., Balter, M., Ford, G., Gervais, A., Goldstein, R., Hodder, R., et al. (2007) · Canadian Respiratory Journal · doi:10.1155/2007/830570 · Cited by 693
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D. A., Barer, M. R., Johnston, S. L., Pavord, I. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1553oc · Cited by 612
Metadata
- Authors
- Ernst, P., Gonzalez, A. V., Brassard, P., & Suissa, S.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-15
- Volume
- 176
- Issue
- 2
- Pages
- 162-166
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2077672954
- Cited by
- 389
- References
- 24
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.